Diabetes and aspirin: new study checks if the pill really works
NCT ID NCT05105919
First seen Dec 08, 2025 · Last updated May 14, 2026 · Updated 18 times
Summary
This study looks at how well a daily low-dose (80 mg) enteric-coated aspirin works in 50 adults with type 2 diabetes who have not taken aspirin recently. Researchers measure blood platelet function before and after 7 days of aspirin to see if the drug fully prevents clotting. The goal is to gather information for a larger future study, not to provide a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
Conditions
Explore the condition pages connected to this study.